[18F]-Fluorodeoxyglucose - A new imaging modality for atherosclerotic plaque thrombogenicity

Circulation Journal

Volumn 77, Issue 10, 2013, Pages 2479-2480

  Kaikita, Koichi ^a   Ogawa, Hisao ^a  

^a KUMAMOTO UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CD163 ANTIGEN; FLUORODEOXYGLUCOSE F 18; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; THROMBOPLASTIN;

ATHEROSCLEROTIC PLAQUE; EDITORIAL; HUMAN; IMAGING; MACROPHAGE; NONHUMAN; POSITRON EMISSION TOMOGRAPHY; THROMBOGENICITY;

ANIMALS; ATHEROSCLEROSIS; CATHETERS; FLUORODEOXYGLUCOSE F18; MAGNETIC RESONANCE ANGIOGRAPHY; MALE; NF-KAPPA B; POSITRON-EMISSION TOMOGRAPHY; RADIOPHARMACEUTICALS; THROMBOPLASTIN; THROMBOSIS;

EID: 84884621404     PISSN: 13469843     EISSN: 13474820     Source Type: Journal    
DOI: 10.1253/circj.CJ-13-1021     Document Type: Editorial

References (15)

1. Lee KW, Lip GY. Acute coronary syndromes: Virchow's triad revisited. Blood Coagul Fibrinolysis 2003; 14: 605-625.
2. Drake TA, Morrissey JH, Edgington TS. Selective cellular expression of tissue factor in human tissues. Implications for disorders of hemostasis and thrombosis. Am J Pathol 1989; 134: 1087-1097.
3. Steffel J, Lüscher TF, Tanner FC. Tissue factor in cardiovascular diseases: Molecular mechanisms and clinical implications. Circulation 2006; 113: 722-731.
4. Zagorchev L, Mulligan-Kehoe MJ. Advances in imaging angiogen-esis and infammation in atherosclerosis. Thromb Haemost 2011; 105: 820-827.
5. Zhao Y, Zhao S, Kuge Y, Strauss WH, Blankenberg FG, Tamaki N. Localization of deoxyglucose and annexin A5 in experimental ath-eroma correlates with macrophage infltration but not lipid deposition in the lesion. Mol Imaging Biol 2011; 13: 712-720.
6. Ogawa M, Ishino S, Mukai T, Asano D, Teramoto N, Watabe H, et al. 18F-FDG accumulation in atherosclerotic plaques: Immunohisto-chemical and PET imaging study. J Nucl Med 2004; 45: 1245-1250.
7. Kaikita K, Ogawa H, Yasue H, Takeya M, Takahashi K, Saito T, et al. Tissue factor expression on macrophages in coronary plaques in patients with unstable angina. Arterioscler Thromb Vasc Biol 1997; 17: 2232-2237.
8. Annex BH, Denning SM, Channon KM, Sketch MH Jr, Stack RS, Morrissey JH, et al. Differential expression of tissue factor protein in directional atherectomy specimens from patients with stable and unstable coronary syndromes. Circulation 1995; 91: 619-622.
9. 18F-fuorodeoxyglucose uptake refects balloon catheter-induced thrombus formation and tissue factor expression via nuclear factor-κB in rabbit atherosclerotic lesions. Circ J 2013; 77: 2626-2635.
10. Patel R, Janoudi A, Vedre A, Aziz K, Tamhane U, Rubinstein J, et al. Plaque rupture and thrombosis are reduced by lowering cholesterol levels and crystallization with ezetimibe and are correlated with fuo-rodeoxyglucose positron emission tomography. Arterioscler Thromb Vasc Biol 2011; 31: 2007-2014.
11. Myers KS, Rudd JH, Hailman EP, Bolognese JA, Burke J, Pinto CA, et al. Correlation between arterial FDG uptake and biomarkers in peripheral artery disease. JACC Cardiovasc Imaging 2012; 5: 38-45.
12. Cunningham MA, Romas P, Hutchinson P, Holdsworth SR, Tipping PG. Tissue factor and factor VIIa receptor/ligand interactions induce proinfammatory effects in macrophages. Blood 1999; 94: 3413-3420.
13. Nakagomi A, Sasaki M, Ishikawa Y, Morikawa M, Shibui T, Kusama Y, et al. Upregulation of monocyte tissue factor activity is signifcantly associated with low-grade chronic inflammation and insulin resistance in patients with metabolic syndrome. Circ J 2010; 74: 572-577.
14. Rominger A, Saam T, Wolpers S, Cyran CC, Schmidt M, Foerster S, et al. 18F-FDG PET/CT identifies patients at risk for future vascular events in an otherwise asymptomatic cohort with neoplastic disease. J Nucl Med 2009; 50: 1611-1620.
15. Paulmier B, Duet M, Khayat R, Pierquet-Ghazzar N, Laissy JP, Maunoury C, et al. Arterial wall uptake of fuorodeoxyglucose on PET imaging in stable cancer disease patients indicates higher risk for cardiovascular events. J Nucl Cardiol 2008; 15: 209-217.